logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Sankar D. Navaneethan

baylor college of medicine

78H指数
455论文数
4.3W被引数
收录论文 188
发表时间
logo
Obesity in CKD: Core Curriculum 2026慢性肾病中的肥胖：核心课程2026
errAmerican Journal of Kidney Diseases
IF8.2
err2026-05-23
err0
PREAI
errHolly J. Kramer; Linda-Marie Lavenburg; Sankar D. Navaneethan
err分享
err收藏
The Association Between Pulmonary Hypertension, End-Stage Kidney Disease and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC)肺动脉高压、终末期肾病与死亡之间的关联：慢性肾功能不全队列研究（CRIC）的分析
errKidney Medicine
IF3.4
err2026-05-12
err0
errOAAI
errMarcelle Tuttle; Hocine Tighiouart; Tatsufumi Oka; Wendy McCallum; Sankar D. Navaneethan; Steven M. Kawut; Mark J. Sarnak
err分享
err收藏
From Loop Diuretics to Closed-Loop Decongestion从袢利尿剂到闭环减充血
errjacc: heart failure
IF0
err2026-05-01
err0
PREAI
errWilfried Mullens; Marnicq van Es; Sankar D. Navaneethan
err分享
err收藏
Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease心血管结局和急性肾损伤风险：2型糖尿病合并慢性肾脏病患者联合疗法研究
errNephrology Dialysis Transplantation
IF5.6
err2026-04-15
err0
PREAI
errAbiodun Idowu; Kevin Bryan Lo; Roy Mathew; Sankar D Navaneethan; Janani Rangaswami
err分享
err收藏
Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease糖尿病和肾脏疾病患者中胰高血糖素样肽-1受体激动剂的证据扩展
errClinical Journal of the American Society of Nephrology
IF7.1
err2026-04-01
err0
PREAI
errHolliday Jr, Michael W.; Navaneethan, Sankar D.
err分享
err收藏
Magnesium, SGLT2 Inhibitors, and Heart Failure镁，SGLT2 抑制剂和心力衰竭
errjacc: heart failure
IF0
err2026-01-05
err0
PREAI
errWendy McCallum; Sankar D. Navaneethan; Mark J. Sarnak
err分享
err收藏
Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney DiseaseGLP-1受体激动剂在慢性肾病中作用的研究现状与未来方向
errInternational Journal of Nephrology and Renovascular Disease
IF2.5
err2026-01-01
err0
errOAAI
errRajan, Kavya; Jutley, Arjun Krishen; Holliday Jr, Michael W.; Navaneethan, Sankar D.
err分享
err收藏
Principles Supporting CKD Management in Primary Care 2025 Veterans Affairs/Department of Defense Clinical Practice Guidelines支持初级保健中CKD管理的原则 2025年退伍军人事务部/国防部临床实践指南
errClinical Journal of the American Society of Nephrology
IF7.1
err2026-01-01
err0
PREAI
errKurella Tamura, Manjula; Sosnov, Jonathan; Delgado, Cynthia; Morrison, John W.; Navaneethan, Sankar D.; Nguyen, Mai T.; Palevsky, Paul M.; Rybacki, Diane; Sall, James; Schwartz, Amy R.; Verma, Sunil P.; Watson, Maura A.; Wickham, Jesse; Fried, Linda
err分享
err收藏
Incident Pulmonary Hypertension and Its Risk Factors in CKD新发肺动脉高压及其在CKD中的危险因素
errCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF7.1
err2025-12-01
err0
PREAI
errTuttle, Marcelle; Tighiouart, Hocine; Oka, Tatsufumi; Mccallum, Wendy; Hill, Nicholas S.; Navaneethan, Sankar; Kawut, Steven M.; Sarnak, Mark J.
err分享
err收藏
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study剂量、治疗模式及非奈利酮在常规治疗中的安全性：一项前瞻性、真实世界和观察性FINE-REAL研究的期中分析
errCLINICAL KIDNEY JOURNAL
IF4.6
err2025-11-01
err0
errOAAI
errWheeler, David C.; Pantalone, Kevin M.; Guo, Lixin; Desai, Nihar R.; Correa-Rotter, Ricardo; Nicholas, Susanne B.; Kim, Nan Hee; Zheng, Zihe; Scott, Charlie; Horvat-Broecker, Andrea; Merz, Martin; Wanner, Christoph; Navaneethan, Sankar D.
err分享
err收藏
Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 DiabetesSGLT2抑制剂对1型糖尿病肾小球滤过率的影响
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2025-10-01
err0
PREAI
errHolliday Jr, Michael W.; Navaneethan, Sankar D.
err分享
err收藏
Kidney Function Decline in Incident Heart Failure Is a Surrogate Marker for Kidney Failure and Mortality肾功能下降是心力衰竭新发患者中肾衰竭和死亡率的替代标志物
errjacc heart failure
IF0
err2025-08-25
err0
PREAI
errCarl P. Walther; Katherine R. Tuttle; Sankar D. Navaneethan
err分享
err收藏
Kidney function trajectories with mechanical circulatory support机械循环支持下的肾功能轨迹
errKidney International Reports
IF5.7
err2025-07-29
err0
errOAAI
errCarl P. Walther; Harveen K. Lamba; Ajith P. Nair; Andrew B. Civitello; Nandan K. Mondal; Kenneth K. Liao; Sankar D. Navaneethan
err分享
err收藏
Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetes非奈利酮与螺内酯在2型糖尿病CKD患者中的高钾血症风险
errNephrology Dialysis Transplantation
IF5.6
err2025-06-01
err0
PREAI
errIdowu, Abiodun; Lo, Kevin Bryan; Adebolu, Olayinka; Hamilton, Michael; Abdelmaseeh, Peter; Navaneethan, Sankar D.; Rangaswami, Janani
err分享
err收藏
Low-Energy Diets: Potential Treatment Option for Patients With Obesity and Early-Stage CKD?低能量饮食：肥胖合并早期CKD患者的潜在治疗选择？
errKidney International Reports
IF5.7
err2025-05-17
err0
errOAAI
errElizabeth C. Lorenz; Sankar D. Navaneethan
err分享
err收藏
GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentaryGLP-1受体激动剂和其他胰高血糖素样肽类似物用于糖尿病和慢性肾脏病——KDIGO评论
errKIDNEY INTERNATIONAL
IF12.6
err2025-05-01
err0
PREAI
errBoer, Ian H. de; Caramori, M. Luiza; Chan, Juliana C. N.; Heerspink, Hiddo J. L.; Khunti, Kamlesh; Liew, Adrian; Michos, Erin D.; Navaneethan, Sankar D.; Olowu, Wasiu A.; Sadusky, Tami; Tandon, Nikhil; Tuttle, Katherine R.; Wilkens, Katy G.; Wilkens, Christoph Katy G.; Zoungas, Sophia
err分享
err收藏
Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis非奈利酮在预设的FIDELITY合并分析中，对于估算肾小球滤过率急性变化患者的疗效与安全性
errKidney International
IF12.6
err2025-04-21
err0
PREAI
errSankar D. Navaneethan; Stefan D. Anker; Gerasimos Filippatos; Bertram Pitt; Peter Rossing; Luis M. Ruilope; Phyllis August; Meike Brinker; Andrea Lage; Luke Roberts; Charlie Scott; Pantelis Sarafidis;
err分享
err收藏
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKDKDOQI美国评论：KDIGO 2024临床实践指南——慢性肾病评估与管理
errAMERICAN JOURNAL OF KIDNEY DISEASES
IF8.2
err2025-02-01
err3
PREAI
errNavaneethan, SD; Bansal, N; Cavanaugh, KL; Chang, A; Crowley, S; Delgado, C; Estrella, MM; Ghossein, C; Ikizler, TA; Koncicki, H; Peter, WS; Tuttle, KR; William, J
err分享
err收藏
Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2024-06-01
err0
PREAI
errUster, Anastasia; Desai, Nihar; Navaneethan, Sankar; Pfarr, Egon; Mazo, Anna Rita
err分享
err收藏
Cystatin C Use for CKD Detection in the Veterans Health Administration System: A Qualitative Study of Barriers and Facilitators
errKIDNEY MEDICINE
IF3.4
err2024-06-01
err0
errOAAI
errLamprea-Montealegre, Julio A.; Shapiro, Abigail; Bontrager, Natalie A. B.; Rifkin, Dena E.; Jassal, Simerjot K.; Gregg, Lucile Parker; Navaneethan, Sankar D.; Navarra, Krista; Shlipak, Michael G.; Estrella, Michelle M.; Wang, Virginia
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Deepak L. Bhatt
H 指数: 197 · 论文数: 3.7K
M
Mark Woodward
H 指数: 176 · 论文数: 1.8K
K
Kamlesh Khunti
H 指数: 162 · 论文数: 2.1K
M
Marcello Tonelli
H 指数: 162 · 论文数: 998
A
Andrew S. Levey
H 指数: 162 · 论文数: 1.0K
查看更多